B E Monk, P H McKee, A du Vivier. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Administration, TopicalAdultFacial Neoplasms/drug therapyHistiocytosis, Langerhans-Cell/drug therapyHistiocytosis, Langerhans-Cell/pathologyHumansMaleMechlorethamine/administration & dosageMechlorethamine/therapeutic useScalp/pathologySkin Neoplasms/drug therapySkin Neoplasms/pathology
Substances: See more » Mechlorethamine
Year: 1985 PMID: 3879287 PMCID: PMC1289450
Source DB: PubMed Journal: J R Soc Med ISSN: 0141-0768 Impact factor: 5.344